PulseTrendingJournal ClubResearchersJournalsExplore
Instagram
HomeTrendingJournal ClubExplore
Synapse
⌘+K
Synapse
March 23, 2024Pediatric Blood & CancerOpen Access

A phase 1/2 study of pepinemab in children, adolescents, or young adults with recurrent or refractory solid tumors: A children's oncology group consortium report (ADVL1614)

View Full Paper
Ask AI
Bookmark
Share

Authors

EGEmily GreengardRWRobin WilliamsBMBranden S. Moriarity

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Greengard et al. (2024) studied this question.

synapsesocial.com/papers/68e72a7db6db6435876a4864https://doi.org/10.1002/pbc.30938
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Tumor angiogenesis and progression are enhanced by Sema4D produced by tumor-associated macrophages2008 · 289 citations
  2. 2Effect of entinostat on NK cell-mediated cytotoxicity against osteosarcoma cells and osteosarcoma lung metastasis2017 · 39 citations
  3. 3The semaphorins.2006 · 413 citations